631例宫颈癌筛查结果分析

Abstract
Figure/Table
References (16)
Related Citation (9)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate cervical cancer screening in Kunshan,and provide reference for better prevention and treatment of cervical cancer.MethodsAnalysized retrospectively the clinical datas of 631 women who received screening cervical cancer and breast cancer from July 1 to November 1 in 2017 in Kunshan Maternal and Child Care Institute.Results Of 631 cases,8 cases(1.3%)aged 30 ～35,64 cases(98.7%)aged 35 ～64.271 cases(43%)had never participated in screening cervical cancer before,360 cases (57%)had participated in cervical cancer screening.260 cases(41.2%)were normal,371 cases（58.8%)were abnormal,including 4 cases trichomonasvaginalis,19 cases vulvoaginalcandidasis,13 cases bacterial vaginosis,9 cases uterine fibroid,242 cases cervicitis,84 cases others.Thinprep cytology test(TCT)of 22 cases(3.5%)were abnormal,among them 17 cases were ASCUS,3 cases were LSIL,2 cases were HSIL.22 cases(3.5%)had histopathologic result,including 4 cases of cervical polyp,2 cases of cervicitis,8 cases found koilocytes,3 cases of low level lesions,4 cases of high level lesions,1 case of cervical invasive squamous cell carcinomas.With the increase of the classification level of TBS in TCT,the probability of pathological changes above the high grade lesions of cervical biopsy increased (P<0.05).The incidence of the high grade lesions of cervical in HPV-positive patients was higher than that of HPV-negative patients,the difference was statistically significant(P<0.05).Conclusion Cervical cancer screening is of great value for early detection of cervical cancer and precancerous lesions and identification of high-risk groups.

Key words： Thinprep cytology test HPV Cervical cancer screening

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Juan
	LIU Yue-hong
	Gu Ping
	MA Xiao-ling

Cite this article:

LI Juan,LIU Yue-hong,Gu Ping, et al. The analysis of 631 cases cervical cancer screening[J]. 中国当代医药, 2018, 25(26): 79-81.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I26/79

[1]	应倩，夏庆民，郑荣寿，等.中国2009年宫颈癌发病与死亡分析[J].中国肿瘤，2013，22（8）：612-616.
[2]	鲍嫘，王春霞.宫颈细胞学检查结合阴道镜检查在宫颈癌筛查中的诊断价值[J].山东医药，2014，54（21）：88-89.
[3]	周健雄，戴意松.液基细胞学检查在宫颈病变筛查中的应用[J].吉林医学，2011，32（20）：4183-4184.
[4]	丁琼.TCT对宫颈癌早期筛查及诊断的意义[J].中国当代医药，2012，19（24）：97-98.
[5]	Clifford GM，Smith JS，Plummer M，et al.Human papilloma virus types in invasive cervical cancer world wide：a meta annlysis[J].Br J Cancer，2003，88（1）：63-73.
[6]	慕建宁，马小红，卢占斌，等.高危型人乳头瘤病毒初筛及液基细胞学分流法在宫颈癌筛查中的应用[J].中国妇幼保健，2017，32（16）：3733-3735.
[7]	韩钦，郭红燕.宫颈癌筛查中HPV检测初筛的分流检测[J].实用妇产科杂志 2016，32（8）：577-579.
[8]	姜艳，孔为民.宫颈癌发病年轻化趋势的研究现状[J].医学综述 2012，18（24）：4166-4169.
[9]	杨慧霞，狄文.妇产科学[M].北京：人民卫生出版社，2016：313-314.
[10]	Dijkstra MG，Snijders PJ，Arbyn M，et al.Cervical cancer screening：on the way to a shift from cytology to full molecular screening[J].Ann Oncol，2014，25（5）：927-935.
[11]	张丹，张宏秀，吴文新.TCT和HPV宫颈癌筛查方法的临床价值[J].江苏医药 2017，43（12）：890-892.
[12]	张宏珍，张巧玉，成争先，等.宫颈细胞学检查为不明确意义的非典型鳞状细胞患者的分流处理探讨[J].重庆医学 2012，41（6）：573-577.
[13]	彭晶晶，王荣敏，尤志学.对ASCCP 2012年宫颈癌筛查和癌前病变管理指南的解读[J].国际妇产科学杂志，2015，42（1）：116-120.
[14]	张小燕，陈庆云，卞美璐.人乳头瘤病毒感染生物状态与宫颈病变研究进展[J].中国妇产科临床杂志，2006，7（2）：147-149.
[15]	吴艳，李炜虹.高危型人乳头瘤病毒检测联合液基薄层细胞学检查筛查宫颈病变[J].现代医学，2015，43（9）：1128-1130.
[16]	杨丽，王静，马彩玲.预防性HPV疫苗预防宫颈癌有效性和安全性Meta分析[J].中华肿瘤防治杂志，2015，22（9）：719-727.